Naproxen-induced liver injury

Hepatobiliary and Pancreatic Diseases International

Volumn 10, Issue 5, 2011, Pages 552-556

  Ali, Sharif ^a   Pimentel, Jason D ^a   Ma, Chan ^a  

^a HENRY FORD HOSPITAL   (United States)

Author keywords

Ductopenia; Liver injury; Naproxen; Propionic acid; Vanishing bile duct syndrome

Indexed keywords

NAPROXEN;

ADULT; ARTICLE; CASE REPORT; CHOLESTASIS; CLINICAL EXAMINATION; FEMALE; HEPATITIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; JAUNDICE; LABORATORY TEST; LIVER BIOPSY; LIVER CELL; LIVER INJURY; LIVER TOXICITY; PRURITUS;

EID: 80053213313     PISSN: 14993872     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1499-3872(11)60093-3     Document Type: Article

References (17)

1. Geubel AP, Sempoux C, Rahier J. Bile duct disorders. Clin Liver Dis 2003;7:295-309.
2. Aithal GP, Day CP. Nonsteroidal anti-inflammatory druginduced hepatotoxicity. Clin Liver Dis 2007;11:563-575.
3. Hussaini SH, Farrington EA. Idiosyncratic drug-induced liver injury: an overview. Expert Opin Drug Saf 2007;6:673-684.
4. Rubenstein JH, Laine L. Systematic review: the hepatotoxicity of non-steroidal anti-inflammatory drugs. Aliment Pharmacol Ther 2004;20:373-380.
5. Alam I, Ferrell LD, Bass NM. Vanishing bile duct syndrome temporally associated with ibuprofen use. Am J Gastroenterol 1996;91:1626-1630.
6. Taghian M, Tran TA, Bresson-Hadni S, Menget A, Felix S, Jacquemin E. Acute vanishing bile duct syndrome after ibuprofen therapy in a child. J Pediatr 2004;145:273-276.
7. Elliott GA, Purmalis A, VanderMeer DA, Denlinger RH. The propionic acids. Gastrointestinal toxicity in various species. Toxicol Pathol 1988;16:245-250.
8. Gay GR. Another side effect of NSAIDs. JAMA 1990;264:2677-2678.
9. Manoukian AV, Carson JL. Nonsteroidal anti-inflammatory drug-induced hepatic disorders. Incidence and prevention. Drug Saf 1996;15:64-71.
10. Andrejak M, Davion T, Gineston JL, Capron JP. Cross hepatotoxicity between non-steroidal anti-inflammatory drugs. Br Med J (Clin Res Ed) 1987;295:180-181.
11. Bass BH. Letter: Jaundice associated with naproxen. Lancet 1974;1:998.
12. Law IP, Knight H. Jaundice associated with naproxen. N Engl J Med 1976;295:1201.
13. Victorino RM, Silveira JC, Baptista A, de Moura MC. Jaundice associated with naproxen. Postgrad Med J 1980;56: 368-370.
14. Giarelli L, Falconieri G, Delendi M. Fulminant hepatitis following naproxen administration. Hum Pathol 1986;17:1079.
15. Demirag MD, Ozenirler S, Goker B, Poyraz A, Haznedaroglu S, Ozturk MA. Idiosyncratic toxic hepatitis secondary to single dose of naproxen. Acta Gastroenterol Belg 2007;70:247-248.
16. Degott C, Feldmann G, Larrey D, Durand-Schneider AM, Grange D, Machayekhi JP, et al. Drug-induced prolonged cholestasis in adults: a histological semiquantitative study demonstrating progressive ductopenia. Hepatology 1992;15: 244-251.
17. Ludwig J, Wiesner RH, LaRusso NF. Idiopathic adulthood ductopenia. A cause of chronic cholestatic liver disease and biliary cirrhosis. J Hepatol 1988;7:193-199.